Remove medicinal-chemistry
article thumbnail

Datavant, Real Chemistry form precision medicine partnership

Outsourcing Pharma

The two firms will work together on solutions to connect de-identified, first-party data to real-world data to help advance precision medicine development.

98
article thumbnail

Rapafusyn's Dr. Rick Ewing Acknowledged With Dual Honors For Exceptional Achievements

pharmaphorum

Baltimore, MD – February 1, 2024 – Rapafusyn proudly announces the distinguished recognition of Dr. Rick Ewing, Vice President of Medicinal Chemistry, for his outstanding contributions to the realms of chemistry and biotechnology innovation

52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

What is the future of biologic medicines?

European Pharmaceutical Review

There are a lot of conjugated products in the clinical pipeline and novel conjugation partners and chemistries are being tried. Two trends that I expect to continue in the foreseeable future are the move towards precision medicine and the diversification of the biologics chemical structures. Bn by 2030. Internet] Globe Newswire.

100
100
article thumbnail

Outsourcing regulatory activities in pharma

European Pharmaceutical Review

1 In the regulatory space, the trend is typically to subcontract about half of the work and do the other half internally, explains Olivier Saslawski, an expert in chemistry, manufacturing and controls (CMC), regulation and pharma outsourcing.

article thumbnail

‘Endless possibilities’: the chemists changing molecules atom by atom

The Guardian - Pharmaceutical Industry

A new method called ‘skeletal editing’ offers a hugely simplified way to alter matter, paving the way for world-changing innovations in personalised medicine and sustainable plastics Ask Mark Levin what excites him about his work, and the associate professor of chemistry at the University of Chicago could double as a poet.

60
article thumbnail

Novel cancer therapeutic synthesised by Stanford researchers

European Pharmaceutical Review

Research published in the journal Nature Chemistry , shows how researchers from Stanford University in the US uncovered a promising new method to synthetically manufacture the compound tigilanol tiglate, named EBC-46, which could offer targeted medicine for cancer and other diseases.

article thumbnail

Click and bio-orthogonal chemistry take Nobel Prize 2022

pharmaphorum

The Royal Swedish Academy of Sciences has decided to award this year’s Nobel Prize in Chemistry to Carolyn R. Barry Sharpless at Scripps Research for elevating chemistry into the era of functionalism. This is Barry Sharpless’ second Nobel Prize in Chemistry – the first was in 2001 for chiral catalysts.

52